We are live on ! Find out more
BCM

Bridgeway Capital Management Portfolio holdings

AUM $4.97B
1-Year Est. Return 44.96%
This Fund
S&P 500
This Quarter Est. Return
+6.61%
1 Year Est. Return
+44.96%
3 Year Est. Return
+114.45%
5 Year Est. Return
+175.29%
10 Year Est. Return
+704.01%
AUM
$4.18B
AUM Growth
+$413M
Cap. Flow
+$293M
Cap. Flow %
7.01%
Top 10 Hldgs %
6.7%
Holding
1,500
New
123
Increased
567
Reduced
324
Closed
123

Top Buys

Rank Stock Value
1
JPM icon
JPMorgan Chase
JPM
+$20M
2
NVDA icon
NVIDIA
NVDA
+$19M
3
JNJ icon
Johnson & Johnson
JNJ
+$14.9M
4
KO icon
Coca-Cola
KO
+$14.6M
5
MSFT icon
Microsoft
MSFT
+$13.7M

Sector Composition

Rank Sector Weight
1 Financials 24.63%
2 Consumer Discretionary 12.15%
3 Technology 12.08%
4 Industrials 12%
5 Healthcare 9.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AAME icon
976
Atlantic American Corp
AAME
$32.6M
$389K 0.01%
201,560
BGSF icon
977
BGSF Inc
BGSF
$60.7M
$387K 0.01%
40,600
-4,500
-10% -$43.2K
GSIT icon
978
GSI Technology
GSIT
$254M
$386K 0.01%
69,717
UEIC icon
979
Universal Electronics
UEIC
$60.6M
$382K 0.01%
39,756
+11,192
+39% +$104K
CTV
980
DELISTED
Innovid Corp.
CTV
$382K 0.01%
+350,000
New +$363K
BDTX icon
981
Black Diamond Therapeutics
BDTX
$110M
$379K 0.01%
75,000
GORV
982
DELISTED
Lazydays
GORV
$378K 0.01%
1,090
-1,256
-54% -$431K
GRTS
983
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
$378K 0.01%
193,900
+11,000
+6% +$25.8K
GATO
984
DELISTED
Gatos Silver, Inc.
GATO
$378K 0.01%
100,000
OKUR
985
OnKure Therapeutics
OKUR
$168M
$377K 0.01%
5,750
+3,250
+130% +$262K
UNB icon
986
Union Bankshares
UNB
$109M
$376K 0.01%
16,390
MTRX icon
987
Matrix Service
MTRX
$330M
$376K 0.01%
63,800
NDLS icon
988
Noodles & Co
NDLS
$108M
$375K 0.01%
13,875
+4,500
+48% +$147K
GURE
989
Gulf Resources
GURE
$4.85M
$374K 0.01%
15,094
CDXS icon
990
Codexis
CDXS
$159M
$371K 0.01%
+132,600
New +$429K
TCFC
991
DELISTED
The Community Financial Corporation Common Stock
TCFC
$371K 0.01%
13,700
-49,005
-78% -$1.39M
METCB icon
992
Ramaco Resources Class B
METCB
$395M
$370K 0.01%
+37,637
New +$363K
AFBI
993
DELISTED
Affinity Bancshares
AFBI
$370K 0.01%
31,500
LBPH
994
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
$367K 0.01%
50,000
PASG icon
995
Passage Bio
PASG
$14.1M
$367K 0.01%
19,480
ELVN icon
996
Enliven Therapeutics
ELVN
$4.31B
$366K 0.01%
17,950
ALXO icon
997
ALX Oncology
ALXO
$284M
$364K 0.01%
+48,500
New +$317K
ABSI icon
998
Absci
ABSI
$1.41B
$364K 0.01%
239,600
+150,000
+167% +$241K
FOSL icon
999
Fossil Group
FOSL
$344M
$360K 0.01%
140,000
-205,000
-59% -$563K
AVAH icon
1000
Aveanna Healthcare
AVAH
$2.03B
$359K 0.01%
212,300
+174,800
+466% +$219K

Similar funds

Bridgeway Capital Management's Q2 2023 Portfolio in Review

As of Q2 2023, Bridgeway Capital Management held 1,500 positions worth $4.18B, up 11% from $3.77B the previous quarter. Its ten largest holdings account for 6.7% of the portfolio.

Bridgeway Capital Management deployed $293M of net new capital in Q2 2023, opening 123 new positions and adding to 567 existing holdings. Its largest new stake was Tronox: 919,025 shares worth $11.7M.

By sector, the portfolio is most concentrated in Financials at 25% of assets, down from 25% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the largest reduction was Permian Resources, an estimated $14.3M trimmed.

  • Bridgeway Capital Management's largest Q2 2023 buy was Tronox: 919,025 shares worth $11.7M.
  • Bridgeway Capital Management added most to JPMorgan Chase in Q2 2023, an estimated $20M increase.
  • Bridgeway Capital Management's biggest Q2 2023 reduction was Permian Resources, cutting an estimated $14.3M.
  • Bridgeway Capital Management fully exited TravelCenters of America LLC in Q2 2023, selling an estimated $21.5M.
  • Bridgeway Capital Management's ten largest holdings make up 6.7% of its $4.18B portfolio in Q2 2023.
  • Bridgeway Capital Management opened 123 new positions and closed 123 in Q2 2023.
  • Bridgeway Capital Management's portfolio value rose 11% quarter-over-quarter to $4.18B.

Based on Bridgeway Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.